Zacks Analyst Blog Features Pfizer, Coca-Cola, Adobe, SAP SE and Glaxo Smith Kline


For immediate release

Chicago, IL – March 15, 2022 – announces the list of stocks featured in the analyst blog. Every day, Zacks Equity Research analysts discuss the latest news and events impacting stocks and financial markets. Stocks recently featured in the blog include: Pfizer Inc. PFE, The Coca-Cola Co. KO, Adobe Inc. ADBE, SAP SE SAP and GlaxoSmithKline plc GSK.

Here are the highlights from Monday’s analyst blog:

Top research reports for Pfizer, Coca-Cola and Adobe

Zacks Research Daily features the best research results from our team of analysts. Today’s Research Daily features new research reports on 16 major stocks, including Pfizer Inc., The Coca-Cola Co. and Adobe Inc.. These research reports have been handpicked from the nearly 70 reports published by our team of analysts today.

You can see all today’s research reports here >>>

Shares of Pfizer outperformed the industry Zacks Large Cap Pharmaceuticals over the past year (+42.0% vs. +18.5%). Pfizer has a diverse portfolio of innovative medicines and vaccines, including Ibrance and Prevnar. The Zacks analyst believes that no company is as strongly positioned in the COVID vaccine/treatment market as Pfizer at present. Its COVID-19 vaccine has become a key revenue contributor. The vaccine combined with Pfizer’s promising oral antiviral pill for COVID-19, Paxlovid, is expected to generate combined sales of $54 billion in 2022.

Pfizer has a sustainable pipeline with several late-stage programs that can drive growth. However, currency headwinds and pricing pressure are the main revenue headwinds. Concerns remain about its long-term growth drivers beyond its COVID-related products due to competitive pressure.

(You can read the full research report on Pfizer here >>>)

Shares of Coca Cola outperformed soft drink industry Zacks Beverages over the past year (+13.5% vs. +7.9%). Coca-Cola’s revenue and net income exceeded estimates for the fourth consecutive quarter. The Zacks analyst believes results benefited from the company’s strategic transformation and the ongoing global recovery.

Income from investments and the ongoing recovery in the markets, where the disruption caused by the pandemic is easing. Strength in most markets, investments in the market, recovery in some markets as well as the cycle of impacts from last year’s pandemic helped volumes.

The company provided an optimistic view of 2022. It is poised to benefit from innovations and accelerating digital investments. However, pressures from higher supply chain costs, including transportation and input costs, persist. Higher marketing spend is also a concern.

(You can read the full Coca-Cola research report here >>>)

Shares of Adobe underperformed the Zacks Computer – Software industry over the past year (-7.0% vs. +9.7%). The Zacks analyst believes that declining end-market demand and high acquisition spending remain major overhangs for the company.

However, Adobe is enjoying strong demand for its cloud products. The company’s Creative Cloud, Document Cloud and Adobe Experience Cloud products help it drive revenue growth. Additionally, rising subscription revenue and strong mobile app momentum remain major positives.

Additionally, growth in emerging markets, strong demand for online video creation, strong adoption of Acrobat, and improving average revenue per user remain supportive. The Zacks analyst remains optimistic about Adobe’s market position, compelling product lines, persistent innovation, and strong adoption of Creative Cloud and Adobe Marketing Cloud.

(You can read the full Adobe research report here >>>)

Other noteworthy reports we feature today include SAP SE and GlaxoSmithKline plc.

Just Released: Zacks Top 10 Stocks for 2022

In addition to the investment ideas discussed above, would you like to know our top 10 buy and hold tickers for all of 2022?

Last year 2021Zacks Top 10 Stocks the portfolio generated gains as high as +147.7%. Now, a brand new portfolio has been selected from over 4,000 companies covered by the Zacks ranking. Don’t miss your chance to participate in this long term shopping

Access the Top 10 Zacks Stocks for 2022 today >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]

Past performance is not indicative of future results. The potential for loss is inherent in any investment. This document is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold any security. No recommendation or advice is given as to whether any investment is suitable for any particular investor. It should not be assumed that investments in the securities, companies, sectors or markets identified and described have been or will be profitable. All information is current as of the date hereof and is subject to change without notice. The views or opinions expressed may not reflect those of the company as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management of securities. These returns come from hypothetical portfolios composed of stocks with Zacks Rank = 1 that have been rebalanced monthly without transaction fees. These are not the returns of actual stock portfolios. The S&P 500 is an unmanaged index. Visit for more information on the performance figures displayed in this press release.

Zacks names ‘only one best choice for doubling up’

From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.

It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could jump in at any moment.

This company could rival or surpass other recent Zacks stocks which are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one. year.

Free: See our best stock and our 4 finalists >>

Click to get this free report

GlaxoSmithKline plc (GSK): Free Stock Analysis Report

CocaCola Company The (KO): Free Stock Analysis Report

Pfizer Inc. (PFE): Free Inventory Analysis Report

SAP SE (SAP): Free Inventory Analysis Report

Adobe Inc. (ADBE): Free Inventory Analysis Report

To read this article on, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


Comments are closed.